---
figid: PMC5593680__oncotarget-08-57733-g003
figtitle: 'Targeting metabolism and AMP-activated kinase with metformin to sensitize
  non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and
  rationale for current clinical trials'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5593680
filename: oncotarget-08-57733-g003.jpg
figlink: /pmc/articles/PMC5593680/figure/F3/
number: F3
caption: Inhibition of mitochondria OxPhos complex I by metformin creates in cancer
  cells a metabolic stress characterized by increased levels of AMP/ADP and potential
  generation of Reactive Oxygen Species (ROS). The first leads to AMPK activation
  through binding on the AMPK γ subunit, while the second is likely responsible for
  the observed trigger of DDR, activation of ATM and induction of γH2Ax foci and activation
  of AMPK. These effects enhance further the activation of AMPK mediated by genotoxic
  stress leading to improved suppression of the downstream events such as the mTOR
  pathway, metabolic gene expression, cell growth, cell cycle progression and survival.
papertitle: 'Targeting metabolism and AMP-activated kinase with metformin to sensitize
  non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and
  rationale for current clinical trials.'
reftext: Michael Troncone, et al. Oncotarget. 2017 Aug 22;8(34):57733-57754.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8889266
figid_alias: PMC5593680__F3
figtype: Figure
redirect_from: /figures/PMC5593680__F3
ndex: 51bdf6fe-df16-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5593680__oncotarget-08-57733-g003.html
  '@type': Dataset
  description: Inhibition of mitochondria OxPhos complex I by metformin creates in
    cancer cells a metabolic stress characterized by increased levels of AMP/ADP and
    potential generation of Reactive Oxygen Species (ROS). The first leads to AMPK
    activation through binding on the AMPK γ subunit, while the second is likely responsible
    for the observed trigger of DDR, activation of ATM and induction of γH2Ax foci
    and activation of AMPK. These effects enhance further the activation of AMPK mediated
    by genotoxic stress leading to improved suppression of the downstream events such
    as the mTOR pathway, metabolic gene expression, cell growth, cell cycle progression
    and survival.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - ATPsynbeta
  - Atpalpha
  - adp
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - tefu
  - Amph
  - Akt
  - Dsor1
  - Mtk
  - SNF4Agamma
  - AMPKalpha
  - gig
  - Erk7
  - rl
  - CycE
  - cyc
  - Rheb
  - Fas2
  - FASN1
  - Fas3
  - fand
  - tei
  - rg
  - FASN2
  - FASN3
  - ATPCL
  - PRAS40
  - Mtor
  - Tor
  - ACC
  - tacc
  - acclinal-wing
  - raptor
  - Thor
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - SREBP
  - SCAP
  - bmm
  - EGFR
  - KRAS
  - ATP8A2
  - WDTC1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - ATM
  - APRT
  - MFAP1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - TSC2
  - EPHB2
  - MAPK1
  - MAPK3
  - RHEB
  - RHEBP1
  - FAS
  - FASN
  - ACLY
  - AKT1S1
  - MTOR
  - ACACA
  - BMS1
  - ACACB
  - EIF4EBP1
  - SREBF2
  - EIF4E
  - EIF4E2
  - EIF4E3
  - SH2D2A
  - Cholesterol
  - Metformin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
---
